tiprankstipranks
Takeda Pharmaceutical Co Ltd (TKPHF)
OTHER OTC:TKPHF
US Market
TKPHF
Takeda Pharmaceutical Co
RESEARCH TOOLSreports
Want to see TKPHF full AI Analyst Report?

Takeda Pharmaceutical Co (TKPHF) Income Statement

35 Followers

Takeda Pharmaceutical Co Income Statement

Last quarter (Q3 2025), Takeda Pharmaceutical Co's total revenue was ¥1.19T, an increase of 4.16% from the same quarter last year. In Q3, Takeda Pharmaceutical Co's net income was ¥103.64B. See Takeda Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T¥ 3.20T
Gross Profit
¥ 2.46T¥ 2.32T¥ 2.30T¥ 2.04T¥ 1.80T
Operating Expenses
¥ 1.83T¥ 1.79T¥ 1.64T¥ 1.43T¥ 1.35T
Depreciation and Amortization
¥ 761.40B¥ 728.00B¥ 664.40B¥ 583.15B¥ 559.67B
EBITDA
¥ 1.13T¥ 927.95B¥ 1.18T¥ 1.04T¥ 1.07T
Operating Income
¥ 627.54B¥ 531.42B¥ 658.29B¥ 610.50B¥ 447.61B
Other Income/Expenses
¥ -452.46B¥ -478.63B¥ -283.20B¥ -307.93B¥ -81.38B
Pretax Income
¥ 175.08B¥ 52.79B¥ 375.09B¥ 302.57B¥ 366.24B
Net Income
¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B¥ 376.00B
Per Share Metrics
Basic EPS
¥ 68.36¥ 92.09¥ 204.29¥ 147.14¥ 240.72
Diluted EPS
¥ 67.23¥ 91.16¥ 201.94¥ 145.87¥ 238.96
Weighted Average Shares Outstanding
 1.58B 1.56B 1.55B 1.56B 1.56B
Weighted Average Shares Outstanding (Diluted)
 1.61B 1.58B 1.57B 1.58B 1.57B
Currency in JPY

Takeda Pharmaceutical Co Earnings and Revenue History